- Home
- UBCP vs COEP Comparison
UBCP vs COEP Comparison
Compare UBCP & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UBCP | COEP |
|---|---|---|
| Founded | 1902 | 2017 |
| Country | United States | United States |
| Employees | N/A | 6 |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.5M | 91.2M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | UBCP | COEP |
|---|---|---|
| Price | $16.26 | $16.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 23.4K | ★ 59.1K |
| Earning Date | 05-08-2026 | 05-13-2026 |
| Dividend Yield | ★ 5.73% | N/A |
| EPS Growth | ★ 5.51 | N/A |
| EPS | ★ 1.34 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.58 | N/A |
| P/E Ratio | $12.23 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.47 | $6.80 |
| 52 Week High | $17.34 | $21.41 |
Technical Indicators
Market Signals| Indicator | UBCP | COEP |
|---|---|---|
| Relative Strength Index (RSI) | 54.55 | 72.18 |
| Support Level | $14.27 | $13.77 |
| Resistance Level | $17.08 | $19.19 |
| Average True Range (ATR) | 0.45 | 1.15 |
| MACD | -0.00 | 0.47 |
| Stochastic Oscillator | 49.32 | 87.62 |
Price Performance
Historical ComparisonAbout UBCP United Bancorp Inc.
United Bancorp Inc operates as a bank holding company that provides commercial and retail banking services. Through its subsidiary (Unified Bank), the company provides a broad range of banking and financial services, which includes accepting demand, savings, and time deposits and granting commercial, real estate, and consumer loans. It serves customers in Belmont, Harrison, Jefferson, Tuscarawas, Carroll, Athens, Hocking, and Fairfield counties and the surrounding localities. The bank also operates in Marshall County West Virginia.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical and technology company. The biopharmaceutical division focuses on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Coeptis aims to advance treatment paradigms and improve patient outcomes through its research and development efforts. The technology division focuses on enhancing operational capabilities through technologies. This division features AI-powered marketing software and robotic process automation tools designed to optimize business processes and improve overall efficiency. It derives the majority of the revenue from the Technology segment.